1 Table of Contents_x000D_
1.1 List of Tables_x000D_
1.2 List of Figures_x000D_
2 Introduction_x000D_
2.1 What Is This Report About?_x000D_
2.2 ENT Devices Market Segmentation_x000D_
2.3 Definitions of Markets Covered in the Report_x000D_
3 ENT Devices Market, United States_x000D_
3.1 ENT Devices Market, United States, Revenue ($m), 2018-2033_x000D_
3.2 ENT Devices Market, United States, Revenue Mix ($m), 2023_x000D_
3.3 ENT Devices Market, United States, Category Contribution by Revenue ($m), 2023_x000D_
3.4 ENT Devices Market, United States, Revenue ($m), 2018-2033_x000D_
3.5 ENT Devices Market, United States, Volume (Units), 2018-2033_x000D_
3.6 ENT Devices Market, United States, Volume (Units), 2018-2033_x000D_
3.7 ENT Devices Market, United States, Company Share by Revenue ($m), 2023_x000D_
4 Balloon Sinuplasty Systems Market, United States_x000D_
4.1 Balloon Sinuplasty Systems Market, United States, Revenue ($m), 2018-2033_x000D_
4.2 Balloon Sinuplasty Systems Market, United States, Volume (Units), 2018-2033_x000D_
4.3 Balloon Sinuplasty Systems Market, United States, Average Price ($), 2018-2033_x000D_
4.4 Balloon Sinuplasty Systems Market, United States, Distribution Share by Revenue ($m), 2023_x000D_
4.5 Balloon Sinuplasty Systems Market, United States, Company Share by Revenue ($m), 2023_x000D_
5 Hearing Implants Market, United States_x000D_
5.1 Hearing Implants Market, United States, Revenue Mix ($m), 2023_x000D_
5.2 Hearing Implants Market, United States, Segment Contribution (%), 2023_x000D_
5.3 Hearing Implants Market, United States, Revenue ($m), 2018-2033_x000D_
5.4 Hearing Implants Market, United States, Volume (Units), 2018-2033_x000D_
5.5 Hearing Implants Market, United States, Average Price ($), 2018-2033_x000D_
5.6 Hearing Implants Market, United States, Distribution Share by Revenue ($m), 2023_x000D_
5.7 Hearing Implants Market, United States, Company Share by Revenue ($m), 2023_x000D_
6 Microdebriders Market, United States_x000D_
6.1 Microdebriders Market, United States, Revenue Mix ($m), 2023_x000D_
6.2 Microdebriders Market, United States, Segment Contribution (%), 2023_x000D_
6.3 Microdebriders Market, United States, Revenue ($m), 2018-2033_x000D_
6.4 Microdebriders Market, United States, Volume (Units), 2018-2033_x000D_
6.5 Microdebriders Market, United States, Average Price ($) , 2018-2033_x000D_
6.6 Microdebriders Market, United States, Distribution Share by Revenue ($m), 2023_x000D_
6.7 Microdebriders Market, United States, Company Share by Revenue ($m), 2023_x000D_
7 Ossicular Reconstruction Devices Market, United States_x000D_
7.1 Ossicular Reconstruction Devices Market, United States, Revenue Mix ($m), 2023_x000D_
7.2 Ossicular Reconstruction Devices Market, United States, Segment Contribution (%), 2023_x000D_
7.3 Ossicular Reconstruction Devices Market, United States, Revenue ($m), 2018-2033_x000D_
7.4 Ossicular Reconstruction Devices Market, United States, Volume (Units), 2018-2033_x000D_
7.5 Ossicular Reconstruction Devices Market, United States, Average Price ($) , 2018-2033_x000D_
7.6 Ossicular Reconstruction Devices Market, United States, Distribution Share by Revenue ($m), 2023_x000D_
7.7 Ossicular Reconstruction Devices Market, United States, Company Share by Revenue ($m), 2023_x000D_
8 Speech Aid Devices Market, United States_x000D_
8.1 Speech Aid Devices Market, United States, Revenue Mix ($m), 2023_x000D_
8.2 Speech Aid Devices Market, United States, Segment Contribution (%), 2023_x000D_
8.3 Speech Aid Devices Market, United States, Revenue ($m), 2018-2033_x000D_
8.4 Speech Aid Devices Market, United States, Volume (Units), 2018-2033_x000D_
8.5 Speech Aid Devices Market, United States, Average Price ($), 2018-2033_x000D_
8.6 Speech Aid Devices Market, United States, Distribution Share by Revenue ($m), 2023_x000D_
8.7 Speech Aid Devices Market, United States, Company Share by Revenue ($m), 2023_x000D_
9 Overview of Key Companies in United States, ENT Devices Market_x000D_
9.1 Medtronic Plc_x000D_
9.1.1 Company Overview_x000D_
9.2 Atos Medical AB_x000D_
9.2.1 Company Overview_x000D_
9.3 Cochlear Ltd_x000D_
9.3.1 Company Overview_x000D_
9.4 Acclarent Inc_x000D_
9.4.1 Company Overview_x000D_
9.5 Grace Medical Inc_x000D_
9.5.1 Company Overview_x000D_
9.6 Heinz Kurz GmbH Medizintechnik_x000D_
9.6.1 Company Overview_x000D_
9.7 Entellus Medical Inc_x000D_
9.7.1 Company Overview_x000D_
9.8 InHealth Technologies_x000D_
9.8.1 Company Overview_x000D_
9.9 Olympus Corp_x000D_
9.9.1 Company Overview_x000D_
9.10 MED-EL Elektromedizinische Gerate Gesellschaft mbH_x000D_
9.10.1 Company Overview_x000D_
9.11 Advanced Bionics LLC_x000D_
9.11.1 Company Overview_x000D_
10 ENT Devices Market Pipeline Products_x000D_
11 Financial Deals Landscape_x000D_
11.1 Acquisition_x000D_
11.1.1 Amplifon Acquires Hearing Instruments and Precision Hearing Aid_x000D_
11.1.2 Laboratory Corp of America Holdings Acquires Xcell Biosciences_x000D_
11.1.3 HearingLife Acquires Hart Hearing_x000D_
11.2 Asset Transactions_x000D_
11.2.1 inHearing Technology Acquires Hearing Health Business from Intricon_x000D_
11.2.2 Shore Capital Partners and C2Dx Acquire Otolaryngology/Head and Neck Surgery Family of Products from Cook Medical_x000D_
11.2.3 Amplifon Acquires Miracle-Ear franchisees in the United States_x000D_
11.3 Debt Offerings_x000D_
11.3.1 Audicus Raises USD0.2 Million in Debt Financing_x000D_
11.3.2 Stryker Raises USD883.83 Million Public Offering of
3.375% Notes Due 2032_x000D_
11.3.3 Stryker Raises USD662.87 Million in Public Offering of
3.625% Notes Due 2036_x000D_
12 Recent Developments_x000D_
12.1 Corporate Communications_x000D_
12.1.1 Sep 14, 2024: Pfizer Presents Positive Data from Phase 2 Study of Ponsegromab in Patients with Cancer Cachexia_x000D_
12.1.2 Sep 14, 2024: Tivic Health Names Lisa Wolf as Interim Chief Financial Officer_x000D_
12.1.3 Jun 18, 2024: Knowles Appoints Jason Cardew to its Board of Directors_x000D_
12.1.4 May 31, 2024: Children’s Hospital of Philadelphia Appoints New Chief of Gastroenterology, Hepatology and Nutrition_x000D_
12.1.5 Apr 08, 2024: CME Corp Announces Expansion of Executive Leadership_x000D_
12.2 Financial Announcements_x000D_
12.2.1 Oct 01, 2024: Stryker to Announce Its Third Quarter 2024 Financial Results_x000D_
12.2.2 Aug 14, 2024: Tivic Reports Second Quarter 2024 Financial Results_x000D_
12.2.3 Aug 02, 2024: Tivic Announces 2024 Annual Meeting of Stockholders_x000D_
12.2.4 Aug 01, 2024: NovaBay Pharmaceuticals to Hold Second Quarter 2024 Conference Call on August 13, 2024_x000D_
12.2.5 Jul 01, 2024: Stryker to Announce Financial Results for its Second Quarter of Fiscal Year 2024_x000D_
12.2.6 May 13, 2024: Tivic Health to Report Q1 2024 Financial Results and Subsequent Events on May 15th Via Conference Call and Webcast_x000D_
12.2.7 Mar 11, 2024: ASE Technology Holding Announces Monthly Net Revenues_x000D_
12.2.8 Feb 13, 2024: Siemens Announces a 22% Increase in Revenue at 14% Pbt (As A % Of Revenue) In Q1 Fy 2024 Results_x000D_
12.3 Government and Public Interest_x000D_
12.3.1 Aug 05, 2024: Netbiologics Receives 510(K) Clearance For Gaudi Proximal Humerus Plate_x000D_
12.3.2 Apr 03, 2024: Envoy Medical to Participate in the LD Micro Invitational XIV Conference April 8 – 9, 2024_x000D_
12.3.3 Feb 22, 2024: Soleno Therapeutics to Present at the TD Cowen 44th Annual Health Care Conference_x000D_
12.4 Legal And Regulatory_x000D_
12.4.1 May 31, 2024: Artera Announces Three Presentations at ASCO 2024 That Demonstrate the Reliability and Depth of its AI Cancer Platform_x000D_
12.5 Other Significant Developments_x000D_
12.5.1 Jun 12, 2024: Remmie Health Awarded NIH SBIR Phase 2 Grant for AI Ear-Nose-Throat (ENT) Diagnostic Assistance Platform_x000D_
12.5.2 Jun 05, 2024: Knowles Extends Custom Miniaturization Capabilities to MedTech OEMs_x000D_
12.6 Product News_x000D_
12.6.1 Oct 16, 2024: Canary Speech Launches Canary Ambient, a First-of-its-Kind, Real-Time Voice Analysis for Clinical Conversations_x000D_
12.6.2 Sep 10, 2024: “Dermatologic Surgery” Journal Publishes Special Issue on Neuromodulators_x000D_
12.6.3 Sep 10, 2024: Canary Speech Receives Patent for Paired Neural Networks Technology_x000D_
12.6.4 Mar 12, 2024: Rexton Launches Rexton Reach Hearing Aid Platform to Ensure Every Voice in Every Conversation is Heard_x000D_
12.6.5 Feb 26, 2024: Radisys Unveils Engage Clarity to Enhance Phone Conversations for People Experiencing Hearing Loss_x000D_
12.6.6 Feb 22, 2024: A Potential New Way to Prevent Noise-Induced Hearing Loss: Trapping Excess Zinc_x000D_
12.6.7 Feb 02, 2024: Academic Presentation at Neuroscience 2023 in the United States – Confirmation of Gamma Wave Synchronization in the Human Brain through Auditory Stimulation-_x000D_
12.7 Strategy And Business Planning_x000D_
12.7.1 Jul 24, 2024: HearUSA Delivers San Marcos Area Residents Access to Better Hearing Health with Opening of a New Hearing Center of the Future in the Springtown Neighborhood_x000D_
12.7.2 Feb 07, 2024: Sonova Opens New Operations Facility Serving Americas Region_x000D_
13 Appendix_x000D_
13.1 Research Methodology_x000D_
13.1.1 Coverage_x000D_
13.1.2 Secondary Research_x000D_
13.1.3 Primary Research_x000D_
13.1.4 Market Modeling and Forecasting_x000D_
13.1.5 Company Share Analysis_x000D_
13.1.6 Distribution Share Analysis_x000D_
13.1.7 Benchmarking_x000D_
13.2 GlobalData Consulting_x000D_
13.3 Contact Us_x000D_
13.4 Disclaimer